Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 5, 2020
Event: Entry into a definitive material agreement involving the issuance of debt and equity securities to raise capital.
Key Financial Metrics and Transaction Details
This filing reports a specific financing transaction rather than periodic financial results. Key metrics from the transaction include:
- Net Proceeds Received: $1,100,000
- Promissory Note Principal: $1,210,000
- Interest Charge: One-time charge of 8%
- Note Maturity Date: February 5, 2021
- Conversion Price: $0.25 per share
- Warrants Issued: 1,000,000 shares at an exercise price of $0.35 per share (5-year term)
- Restricted Shares Issued: 200,000 shares ("Inducement Shares")
Material Changes and Terms
The company entered into a securities purchase agreement with LGH Investments, LLC. The transaction structure includes:
- Debt Instrument: A convertible promissory note with a principal amount exceeding the cash received, reflecting the inclusion of an 8% interest charge.
- Equity Instrument: Warrants subject to a full-ratchet adjustment upon certain dilutive issuances.
- Inducement Shares Protection: A provision requiring the company to issue additional shares if the share price declines before the removal of the restricted legend, ensuring the aggregate value of the Inducement Shares remains equal to their value on June 5, 2020.
- Exemption: Securities were sold under Section 4(a)(2) of the Securities Act of 1933.
Outlook, Risks, and Contingencies
Management Commentary: The filing does not contain forward-looking guidance or management commentary regarding future operations beyond the terms of the agreement.
Risks and Contingencies:
- Dilution Risk: The full-ratchet provision on warrants and the price protection on Inducement Shares create significant potential for future dilution to existing shareholders.
- Liquidity Obligation: The company has a direct financial obligation to repay $1,210,000 by February 5, 2021, unless converted.
- Registration Status: Warrants may be exercised on a cashless basis if no effective registration statement is in place after the applicable holding period.
Investor Verification Checklist
- Verify the company's current cash position to assess ability to service the $1,210,000 debt obligation by February 2021.
- Review the full text of Exhibits 10.1, 10.2, and 10.3 for specific triggers regarding the full-ratchet adjustment and Inducement Share valuation.
- Monitor the company's share price relative to the $0.25 conversion price and $0.35 warrant exercise price.
- Check for any subsequent filings regarding the registration of shares underlying the warrants.